Anthony Carlo
Papers
1
Total Citations
7
H-Index
1
About
Anthony Carlo is a rising leader in drug metabolism and pharmacological screening, whose work bridges cutting-edge assay development with translational drug safety. His most-cited research, "Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes" (2024, 7 citations), introduces a paradigm-shifting approach to early-stage drug discovery. By enabling simultaneous, high-throughput evaluation of multiple drug-metabolizing enzymes in physiologically relevant human hepatocyte models, Carlo’s method dramatically accelerates the identification of selective inhibitors—critical for predicting drug-drug interactions and toxicity. This work addresses a long-standing bottleneck in pharmaceutical development, where traditional single-enzyme assays often fail to capture complex metabolic contexts. Though early in his career, Carlo’s contributions have already garnered attention for their potential to reduce late-stage clinical failures. His research exemplifies a commitment to precision pharmacology, integrating multiplexed technologies with human-relevant systems to enhance the safety and efficacy of new therapeutics. As the field increasingly prioritizes human-based models over animal testing, Carlo’s innovations position him as a key architect of next-generation drug screening platforms.
Research Focus
Key Achievements
Top Papers
- 1